Question 1

What are the potential benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients clinical trial (NCT07138755). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from the combination of Sintilimab and chemotherapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients clinical trial (NCT07138755). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients clinical trial (NCT07138755). Contact the study team or your healthcare provider for specific answers.

Question 4

What tests will be done to monitor my progress during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients clinical trial (NCT07138755). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with the adaptive radiotherapy part of the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients clinical trial (NCT07138755). Contact the study team or your healthcare provider for specific answers.

Question 6

How will this trial fit into my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients clinical trial (NCT07138755). Contact the study team or your healthcare provider for specific answers.

What this study is about